Publicaciones en las que colabora con ROSARIO GIL BENSO (20)

2017

  1. Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2

    Cytotechnology, Vol. 69, Núm. 4, pp. 539-550

2015

  1. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status

    Neuroscience, Vol. 297, pp. 243-251

  2. Evolution to malignancy: A genetic stepwise study of tumor suppressor genes loss in a recurrent meningioma

    Clinical Neuropathology

  3. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma

    Pathology and Oncology Research, Vol. 21, Núm. 4, pp. 1191-1199

2014

  1. BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of ota

    Journal of Clinical Oncology, Vol. 32, Núm. 20

  2. Correlation between EGFR amplification and the expression of MicroRNA-200c in primary glioblastoma multiforme

    PLoS ONE, Vol. 9, Núm. 7

  3. Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation

    BMC Cancer, Vol. 14, Núm. 1

2013

  1. Chromosomal and genetic changes produced in tumoral progression of embryonal rhabdomyosarcoma

    Histopathology

2012

  1. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: New predictive factors of tumor progression in cutaneous malignant melanoma

    Clinical and Experimental Metastasis, Vol. 29, Núm. 6, pp. 625-637

  2. Characterization of a new human melanoma cell line with CD133 expression

    Human Cell, Vol. 25, Núm. 2, pp. 61-67

2007

  1. Concurrent EGFR amplification and TP-53 mutation in glioblastomas

    Clinical Neuropathology, Vol. 26, Núm. 5, pp. 224-231

2005

  1. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme

    Clinical Neuropathology, Vol. 24, Núm. 5, pp. 209-218

2004

  1. Association of loss of 1p and alterations of chromosome 14 in meningioma progression

    Cancer Genetics and Cytogenetics, Vol. 148, Núm. 2, pp. 123-128

2003

  1. Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: Comparative histologic and genetic studies with its tumor of origin

    Laboratory Investigation, Vol. 83, Núm. 6, pp. 877-887

2001

  1. Characterization of a new rat cell line established from 2′-induced combined hepatocellular cholangiocellular carcinoma

    In Vitro Cellular and Developmental Biology - Animal, Vol. 37, Núm. 1, pp. 17-25

1996

  1. Oxidative metabolism in a rat hepatoma (N13) and isolated rat hepatocytes: A flow cytometric comparative study

    Hepatology, Vol. 24, Núm. 2, pp. 385-390

1992

  1. Cytogenetics, flow cytometry, cytophotometry and morphometry of 22 cases of primary breast carcinoma - A comparative study

    Virchows Archiv B Cell Pathology Including Molecular Pathology, Vol. 61, Núm. 1, pp. 133-140

1991

  1. Cytophotometric analysis of glycogen, protein and DNA of a glycogen-storing rat hepatoma (N13) cell line

    Virchows Archiv B Cell Pathology Including Molecular Pathology, Vol. 60, Núm. 1, pp. 271-278

1989

  1. Absence of γGT expression in syrian golden hamster liver during hepatocarciogenesis by N-nitrosomorphine. Optical and structural study of altered hepatocytes foci

    Oncologia, Vol. 12, Núm. 1, pp. 14-22

1987

  1. Morphometric and cytophotometric nuclear analysis of altered hepatocyte foci induced by N-nitrosomorpholine (NNM) and aflatoxin B1 (AFB1) in liver of Wistar rats

    Virchows Archiv B Cell Pathology Including Molecular Pathology, Vol. 54, Núm. 1, pp. 341-349